Effective delivery of therapeutic and diagnostic nanoparticles is dependent on their ability to
accumulate in diseased tissues. However, most nanoparticles end up in liver macrophages …

Nanomaterials (NMs) are widely used in commercial and medical products, such as
cosmetics, vaccines, and drug carriers. Exposure to NMs via various routes such as dermal …

Hepatocellular carcinoma (HCC), one of the most malignant tumors, is characterized by its
stubborn immunosuppressive microenvironment. As one of the main members of the tumor …

Targeted fluorescence probes for imaging and differentiation of hepatocellular carcinoma
(HCC) are highly desirable from its scientific research and clinical applications. However …

The failure of immune responses to vaccines and dysfunctional immune responses to viral
infection, tumor development, or neoantigens lead to chronic viral infection, tumor …

Simple Summary Hepatocellular carcinoma (HCC) is characterized by a broad molecular
and genetic heterogeneity, which makes it a challenging subject in terms of the underlying …

Chronic hepatitis B virus (HBV) infection affects more than 250 million people worldwide,
which greatly increases the risk for terminal liver diseases, such as liver cirrhosis and …

Breast cancer is the most frequent cancer among females and the second most common
cause of cancer deaths worldwide. Tumor-associated macrophages (TAMs) are the most …

Cancer nanomedicine has emerged as a promising approach to overcome the limitations of
conventional cancer therapies, offering enhanced efficacy and safety in cancer …

The natural polymer, lignin, possesses unique biodegradable and biocompatible properties,
making it highly attractive for the generation of nanoparticles for targeted cancer therapy. In …